Table 3.

Baseline values and changes in z-scores per month for overall patients as well as in different clinical categories.

Clinical parameters	N (%)	TMT-A Z score				TMT-B Z score				DB Z score
		Baseline	Change	95% CI	p-value	Baseline	Change	95% CI	p-value	Baseline	Change	95% CI	p-value
All patients	46 (100)	−1.42	0.024	0.006–0.042	0.009	−2.01	0.034	0.012–0.057	0.003	−0.53	0.019	0.011–0.028	<0.001
Psychiatric comorbidity
No	34 (73.9)	−0.99	0.018	−0.01–0.040	0.13	−1.55	0.025	0.004–0.047	0.018	−0.34	0.017	0.007–0.026	0.001
Yes	12 (26.1)	−2.61	0.042	0.014–0.07	0.003	−3.58	0.058	0.004–0.113	0.036	−1.13	0.028	0.009–0.046	0.003
Epilepsy type
FLE	18 (39.1)	−1.57	0.030	−0.01–0.07	0.142	−2.38	0.032	−0.014–0.079	0.172	−0.80	0.013	0.0–0.026	0.055*
TLE	17 (37)	−1.79	0.024	0.002–0.044	0.028	−2.37	0.040	0.006–0.074	0.020	−0.74	0.012	−0.003–0.026	0.120
Other	11 (23.9)	−0.89	−0.009	−0.084–0.065	0.810	−1.13	0.008	−0.036–0.053	0.717	0.18	0.003	−0.018–0.023	0.795
Predominant seizure type
FAS/FIAS	34 (73.9)	−1.17	0.019	−0.005–0.043	0.123	−1.74	0.034	0.009–0.058	0.006	−0.45	0.018	0.008–0.029	0.001
FBTCS	12 (26.1)	−2.37	0.035	0.009–0.061	0.008	−3.12	0.025	−0.029–0079	0.37	−0.73	0.018	0.004–0.033	0.013
ASMs
1–2	17 (37)	−0.90	0.042	0.015–0.068	0.002	−0.98	0.042	0.014–0.071	0.004	−0.10	0.014	−0.003–0.031	0.114
3–4	29 (63)	−1.77	0.012	−0.011–0.035	0.312	−2.76	0.030	−0.001–0.060	0.058	−0.80	0.023	0.013–0.033	<0.001

ASM, antiseizure medication; FAS, focal aware seizure; FBTCS, focal to tonic clonic seizure; FIAS, focal impaired awareness seizure; FLE, frontal lobe epilepsy; TLE, temporal lobe epilepsy. Bold values indicate statistically significant p-values.